| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| PhaseBio Pharmaceuticals Inc | SVP, Technical Operations | Employee Stock Option (right to buy) | 87,500 | 24 Feb 2022 | Direct | ||
| PhaseBio Pharmaceuticals Inc | SVP, Technical Operations | Common Stock | 41,236 | 20 May 2022 | Direct | ||
| PhaseBio Pharmaceuticals Inc | SVP, Technical Operations | Restricted Stock Unit | 18,750 | 24 Feb 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000116924522000079-arnold-susan-elizabeth-2022-05-20 | PhaseBio Pharmaceuticals Inc | 20 May 2022 | 1 | +$7,438 | 4 | SVP, Technical Operations | 24 May 2022, 17:15 |
| /report/000116924522000009-arnold-susan-elizabeth-2022-02-24 | PhaseBio Pharmaceuticals Inc | 24 Feb 2022 | 2 | $0 | 4 | SVP, Technical Operations | 28 Feb 2022, 18:21 |
| /report/000116924521000128-arnold-susan-elizabeth-2021-11-19 | PhaseBio Pharmaceuticals Inc | 19 Nov 2021 | 1 | +$5,144 | 4 | SVP, Technical Operations | 23 Nov 2021, 17:54 |
| /report/000116924521000089-arnold-susan-elizabeth-2021-07-12-restatement | PhaseBio Pharmaceuticals Inc | 12 Jul 2021 | 2 | +$7,863 | 4/A | VP, Preclinical and Chem | 03 Sep 2021, 16:43 |
| /report/000116924521000043-arnold-susan-elizabeth-2021-05-20 | PhaseBio Pharmaceuticals Inc | 20 May 2021 | 1 | +$14,720 | 4 | VP, Preclinical and Chem | 24 May 2021, 18:09 |